Abbreviations
Cancer Patients Europe is a pan-European and all-cancer type association that, uniting cancer patients, carers, and survivors, envisions reducing the burden of cancer on patients and survivors, their carers, the health care systems, and society as a whole across the European continent.
CPE’s core mission is to represent and empower the voices of cancer patients and cancer survivors, advocating for their needs and rights at every stage of their journey. CPE works alongside policymakers, healthcare professionals, and other stakeholders to co-create policies that promote prevention, high-quality care, treatment, and support survivorship.
What is CPE’s main role?
Support project planning and coordination including reporting, data quality and risk management and internal communication
Contribute to the social and economic impact assessment by supporting the health economic impact evaluation, the implementation process of the GLIOMATCH platform, as well as the development and optimisation of the multiomics hub
Carry out stakeholder engagement planning, including stakeholder mapping, raising awareness on the project, and dissemination of outcomes
Which work packages is CPE involved in?
See our dedicated page for more details on the GLIOMATCH work plan.
CPE is mainly involved in work package 7 and also supports work packages 6 and 8
Who will represent CPE?
GLIOMATCH Partners
